Eli Lilly to halt development of Alzheimer’s treatment candidate March 9, 2023 AutoBot Uncategorized 0 Eli Lilly is halting development of solanezumab after it failed to slow cognitive decline in a study of patients at risk of Alzheimer’s disease, the drugmaker said March 8.